H.R. 4114 · 117th Congress · House

Allergy Testing Access Act of 2021

Active· Referred to the Subcommittee on Health.
Introduced
Jun 24, 21
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Allergy Testing Access Act of 2021

This bill requires equal coverage of two types of allergy tests under Medicaid and Medicare.

Specifically, in vitro specific IgE tests (blood tests) and percutaneous tests (skin tests) must be treated equally with respect to (1) medical necessity or other coverage requirements, (2) frequency limits, and (3) allergen unit limits.

Action Timeline

6
  1. JUN 25, 2021•Committee

    Referred to the Subcommittee on Health.

  2. JUN 24, 2021•IntroReferral

    Introduced in House

  3. JUN 24, 2021•IntroReferral

    Introduced in House

  4. JUN 24, 2021•IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  5. JUN 24, 2021•IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  6. JUN 24, 2021•Committee

    Referred to the Subcommittee on Health.

Committees

4

Health Subcommittee

hsif14

Referred: Jun 25, 2021

Active

Health Subcommittee

hswm02

Referred: Jun 24, 2021

Active

Ways and Means Committee

hswm00

Referred: Jun 24, 2021

Active

Energy and Commerce Committee

hsif00

Referred: Jun 24, 2021

Active